The episode discusses preventative care, specifically how virtual care can help people with chronic conditions manage their health and avoid hospitalization. David Dlesk, CEO and Co-Founder of Embrace Prevention Care, shares an overview of the challenges of preventative care in the current healthcare system and how Embrace helps patients with chronic conditions, like dementia, take action to improve their health.

Embrace uses virtual consultations with nurse practitioners to provide ongoing support and coaching to patients. This helps patients make the lifestyle changes necessary to slow the progression of their chronic conditions. The Centers for Medicare & Medicaid (CMS) has created a new program, GUIDE, to specifically target dementia patients and caregivers. Embrace is one of the select organizations chosen to provide this program.

The key takeaways from the podcast episode are:

• Preventative care is not currently well- incentivized in the healthcare system, but it is critical for managing chronic conditions.
• Virtual care can be an effective way to deliver preventative care.
• Embrace is a company that is using virtual care to help people with chronic conditions manage their health and avoid hospitalization.
• CMS has created a new program, GUIDE, to provide virtual preventative care to dementia patients and caregivers.

This episode features Ben Holmes, CEO and Co-founder of Nanochon, a medical device company focused on revolutionizing cartilage repair. The discussion highlights the significant challenges faced by patients with cartilage damage, including limited treatment options and the potential for further joint degeneration.

Nanochon is developing a groundbreaking 3D-printed implant designed to mimic the natural structure and function of cartilage. This innovative device is designed to be minimally invasive and easily implanted, offering a potential solution for patients facing cartilage damage and potentially delaying or even preventing the need for knee replacement surgery.

Ben shares insights into Nanochon's development progress, including upcoming human trials and their recent move to LaunchPort in Baltimore, a unique incubator space that provides access to state-of-the-art manufacturing facilities for medtech startups. With team expansion plans on the horizon, this story is fueled with insights, sure to leave you informed and inspired.

This episode discusses a huge unmet need in the medical device space: treatment for mixed urinary incontinence. Millions of patients, primarily women, suffer from this condition, and there is no effective treatment on the market. Current treatment options leave care gaps and patients resorting to over-the-counter products for symptom management.

Juniper Biomedical is a company that is developing a new type of treatment for mixed urinary incontinence. They are developing a unique neuromodulation micro implant that can be implanted with a minimally invasive procedure to deliver a very precise therapy. This has the potential to solve the problems of mixed incontinence, eliminate issues with inaccurate diagnosis, and importantly, provide a solution that patients are more likely to accept.

CEO and co-founder, David Constantine joins us to discuss their exciting progress, from extensive preclinical studies, to upcoming clinical trials. After a year of multiple highlights, including award winning on the stage of Medtech Innovator, the future looks bright for Juniper Biomedical. Their technology has the potential to make a real difference in the lives of millions of patients with pelvic health conditions, a story sure to leave you, informed and inspired.